Ocular Therapeutix (OCUL) Finished Goods (2014 - 2026)

Ocular Therapeutix's Finished Goods history runs 13 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• On a quarterly basis, Finished Goods rose 72.91% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 72.91% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 22.74% from the prior year.
• Finished Goods climbed to $2.2 million in Q1 2026 per OCUL's latest filing, from $1.6 million in the prior quarter.
• Across five years, Finished Goods topped out at $2.2 million in Q1 2026 and bottomed at $343000.0 in Q3 2022.
• The 5-year median for Finished Goods is $1.2 million (2023), against an average of $1.1 million.
• Across the five-year window, Finished Goods jumped 198.05% in 2022 and dropped 20.45% in 2024, its largest moves.
• Year by year, Finished Goods stood at $766000.0 in 2022, then increased by 29.37% to $991000.0 in 2023, then soared by 34.91% to $1.3 million in 2024, then increased by 22.74% to $1.6 million in 2025, then jumped by 34.55% to $2.2 million in 2026.
• Per Business Quant, the three latest OCUL Finished Goods figures stand at $2.2 million (Q1 2026), $1.6 million (Q4 2025), and $1.9 million (Q3 2025).